glutathione and ovarian cancer

glutathione and ovarian cancer Role of SLC7A11/xCT in Frontiers | Glutathione-responsive and -exhausting

Name: glutathione and ovarian cancer Role of SLC7A11/xCT in Frontiers | Glutathione-responsive and -exhausting
Brand: www.djecji-vrtic-kucica.hr
SKU: 42074164502
Price: 20.52 USD
Availability: InStock
Rating: 4.7659 (16 reviews)

Frontiers Glutathione responsive and exhausting metal nanomedicines for robust synergistic cancer therapy Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity Scientific Reports Glutathione as a Prognostic Biomarker and a Potential Therapeutic Target for Ovarian Cancer Frontiers Unveiling drug resistance pathways in high grade serous ovarian cancer(HGSOC): recent advances and future perspectives

SKU: 42074164502 · From www.djecji-vrtic-kucica.hr

4.8

USD20.52 USD47.52

Pay in 4 interest-free payments of $5.13 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

Description

Growth Factors, 22 (3), 123131

Claudel T, Inoue Y, Barbier O, Duran-Sandoval D, Kosykh V, Fruchart J, et al

Bin P, Huang R, Zhou X

N6-methyladenosine (m 6 A) demethylase FTO is significantly upregulated in MPP + -stimulated SK-N-SH cells, which suppresses YTH domain family protein 2 (YTHDF2) expression, promotes m 6 A demethylation of BRCA1-associated protein 1 (BAP1) and enhances BAP1 expression, upregulates p53 expression, and inhibits SLC7A11 transcription, thereby increasing MDA, Fe 2+ , and 4-HNE levels and triggering neuronal ferroptosis